IP Library Granted Patent US 7,655,129
Granted Patent B2
US 7,655,129 · App. 10/823,503 · Granted Feb 2, 2010

Binding acceleration techniques for the detection of analytes

Assignee: Osmetech Technology Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,655,129
App. No.
10/823,503
Granted
Feb 2, 2010
Kind
B2
Abstract

The invention relates to compositions and methods useful in the acceleration of binding of target analytes to capture ligands on surfaces. Detection proceeds through the use of an electron transfer moiety (ETM) that is associated with the target analyte, either directly or indirectly, to allow electronic detection of the ETM.

Claims (32)

1. A method of detecting a target analyte in a sample comprising:

a) adding said sample to a detection chamber comprising a detection electrode comprising a self assembled monolayer and a capture ligand bound to said self assembled monolayer using biotin and streptavidin;

b) mixing said sample such that said target analyte binds to said capture ligand to form an assay complex, wherein said assay complex further comprises at least one electron transfer moiety (ETM); and

c) detecting the presence of said ETM using said detection electrode.

2. A method according to claim 1 wherein each of said detection electrodes is “sunken” or “recessed” with respect to the chamber, such that the flow of said sample past each of said detection electrodes causes said mixing.

3. The method of claim 1 or 2 wherein said detecting comprises amperommetry.

4. The method of any one of claims 1 wherein said ETM is a hybridization indicator.

5. The method of claim 4 wherein said ETM comprises a transition metal complex.

6. The method of claim 4 wherein said detecting comprises amperommetry.

7. The method of claim 4 wherein said detecting comprises voltammetry.

8. The method of claim 4 wherein said detecting comprises capacitance measurement.

9. The method of claim 4 wherein said detecting comprises impedence measurement.

10. The method of claim 1 or 2 wherein said detecting comprises capacitance measurement.

11. The method of claim 1 or 2 wherein said detecting comprises impedence measurement.

12. The method of claim 1 or 2 wherein said detecting comprises voltammetry.

13. The method of claim 1 or 2 wherein said detecting comprises amperommetry.

14. A method of detecting a target analyte in a sample comprising:

a) adding said sample to a detection chamber comprising a detection electrode comprising a self assembled monolayer and a capture ligand bound directly or indirectly to said self assembled monolayer;

b) mixing said sample such that said target analyte binds to said capture ligand to form an assay complex, wherein said assay complex further comprises at least one electron transfer moiety (ETM); and

c) detecting the presence of said ETM using said detection electrode, wherein said detection electrode is sunken or recessed with respect to said chamber such that the flow of said sample past said detection electrode causes said mixing.

15. A method according to claim 1 or 14 wherein said capture ligand comprises a nucleic acid.

16. The method of claim 15 wherein said target analyte is a nucleic acid and said method further comprises amplifying said nucleic acid analyte with PCR prior to binding to said capture ligand.

17. A method according to claim 1 or 14 wherein said mixing is accomplished by applying an AC/DC pulse.

18. A method according to claim 1 or 14 wherein said mixing is accomplished through the use of mixing particles.

19. A method according to claim 18 wherein said mixing particles comprise microparticulate matter.

20. A method according to claim 1 or 14 wherein said mixing is accomplished through the use of an electrophoretic electrode.

21. The method of claim 1 or 14 wherein said monolayer insulates against one or more of nonspecific binding and nonspecific signaling.

22. The method of claim 1 or 14 wherein said detection electrode is present among an array of detection electrodes.

23. The method of claim 14 wherein said capture ligand is bound to said self-assembled monolayer using biotin and streptavidin.

24. The method of claim 23 wherein said target analyte is a nucleic acid and said method further comprises amplifying said nucleic acid analyte with PCR prior to binding to said capture ligand.

25. The method of claim 1 or 14 , wherein said ETM is a ferrocene.

26. The method of claim 1 or 14 , wherein said ETM is a redox protein.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2017
From: KAYYEM, JON FAIZ
To: CLINICAL MICRO SENSORS, INC., (DBA OSMETECH TECHNOLOGY INC.)
Reel/Frame 043601/0737 →
RELEASE OF SECURITY INTEREST Recorded Oct 9, 2012
From: SQUARE 1 BANK
To: OSMETECH TECHNOLOGY, INC.
Reel/Frame 029097/0148 →
SECURITY INTEREST Recorded Apr 1, 2010
From: OSMETECH TECHNOLOGY INC.
To: SQUARE 1 BANK
Reel/Frame 024312/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2009
From: CLINICAL MICRO SENSORS, INC., DBA OSMETECH MOLECULAR DIAGNOSTICS
To: OSMETECH TECHNOLOGY INC.
Reel/Frame 022378/0868 →
Continuity (5)
Continuation 0952047700 · Mar 8, 2000
Division 0933872600 · Jun 23, 1999
Continuation 0913405800 · Aug 14, 1998
Provisional Application 6009038900 · Jun 23, 1998
Related Publication 20050003399A1 · Jan 6, 2005